• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-08

  The reference study uncovers a mechanism by which the transcription factor HOXC8 suppresses pyroptotic cell death in non-small cell lung carcinoma (NSCLC) through direct repression of caspase-1 expression. This finding clarifies a novel regulatory axis in tumorigenesis and suggests new opportunities for investigating caspase signaling in inflammation and cancer.

• MiR-3180 Suppresses HCC via SCD1 and CD36-Mediated Lipid Pat

  2026-07-07

  Hong et al. demonstrate that miR-3180 inhibits hepatocellular carcinoma (HCC) growth and metastasis by targeting both lipid synthesis and uptake through direct suppression of SCD1 and CD36. These findings reveal miR-3180 as a dual-action regulator and potential therapeutic target for metabolic intervention in HCC.

• Exo1: Applied Workflows for Precision Membrane Trafficking I

  2026-07-07

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) delivers targeted, rapid inhibition of exocytic pathways, enabling researchers to dissect membrane trafficking and tumor extracellular vesicle dynamics with high specificity. Its unique ARF1 release mechanism offers an edge over legacy tools for advanced exocytosis assays and troubleshooting complex workflows.

• Sodium Phosphate Dibasic: Precision Buffering in Ecotoxicolo

  2026-07-06

  Explore the unique role of sodium phosphate dibasic (Na2HPO4) as an advanced biological assay buffer in aquatic toxicity research. Discover how high-purity Na2HPO4 empowers modern ecotoxicology, grounded in cutting-edge evidence and protocol-level insight.

• JAK Inhibitors and Endothelial Dysfunction: Vascular Effects

  2026-07-06

  This study systematically compares the vascular effects of several JAK inhibitors, including tofacitinib citrate (CP-690550 citrate), on human endothelial cells exposed to proinflammatory cytokines. The research illuminates both common and distinct impacts on inflammatory signaling, adhesion molecule expression, and endothelial cell survival, providing crucial insights for cardiovascular safety assessment in immune regulation research.

• AG-126 (Tyrphostin AG-126): Reliable ERK1/2 Inhibition in Ce

  2026-07-05

  This article addresses laboratory challenges in cell viability and signaling assays where consistent ERK1/2 pathway inhibition is essential. Drawing on validated studies and the unique attributes of AG-126 (Tyrphostin AG-126) (SKU C4338), it provides scenario-driven guidance for optimizing experimental reproducibility and interpreting mechanistic findings in neurobiology and inflammation models.

• Wnt-C59: Advancing Precision Wnt Pathway Modulation in Trans

  2026-07-04

  This thought-leadership article explores the transformative role of Wnt-C59 as a nanomolar-selective PORCN inhibitor in the evolving landscape of cancer biology and regenerative medicine. Blending mechanistic clarity with strategic guidance, it addresses the nuances of Wnt secretion inhibition, apoptosis induction in cholangiocarcinoma models, and the broader implications for translational workflows. Key findings from recent exosomal Wnt signaling research are integrated, situating Wnt-C59 at the forefront of both experimental rigor and clinical promise, while providing actionable protocol parameters for advanced researchers.

• Cholecystokinin-Octapeptide Reverses Morphine-Impaired LTP i

  2026-07-03

  This study demonstrates that cholecystokinin-octapeptide (CCK-8) restores hippocampal long-term potentiation (LTP) deficits induced by acute morphine exposure in rats, primarily via CCK2 receptor activation. The findings establish a mechanistic link between CCK-8 signaling and the mitigation of opioid-induced cognitive impairment, offering a foundation for future research on neuroprotection and synaptic plasticity.

• Resibufogenin Inhibits NLRP3 Inflammasome to Alleviate Ather

  2026-07-03

  This study demonstrates that resibufogenin (RBG) protects against atherosclerosis in ApoE-/- mice by directly blocking NLRP3 inflammasome assembly. Through molecular, cellular, and animal models, RBG was found to reduce inflammatory responses and lipid accumulation, offering a promising new approach for cardiovascular disease intervention.

• CD36-Driven Lipid Metabolism Enables Immune Escape in AML

  2026-07-02

  Guo et al. illuminate how CD36-dependent lipid uptake in acute myeloid leukemia (AML) orchestrates non-canonical immune signaling, suppressing T cell activity and conferring resistance to hypomethylating agent therapy. Their mechanistic insights into the synergy between oxidized LDL and palmitate reveal pivotal metabolic vulnerabilities, with translational implications for overcoming immune evasion in AML.

• Amphotericin B: Polyene Antifungal Antibiotic for Biofilm Mo

  2026-07-02

  Amphotericin B stands apart as a gold-standard polyene antifungal antibiotic for research, offering unmatched potency against resistant fungal biofilms and prion models. This guide translates recent mechanistic advances into actionable protocols, troubleshooting, and workflow upgrades for infection and immunomodulation assays.

• Viral Modulation of RIPK3 and Necroptosis in Inflammation Co

  2026-07-01

  Liu et al.'s study uncovers a class of viral proteins in orthopoxviruses that promote the degradation of the necroptosis adaptor RIPK3, thereby modulating virus-induced inflammation and pathogenesis. These findings clarify how viral evasion of regulated cell death pathways shapes host-pathogen dynamics and may inform targeted approaches in cell death and inflammation research.

• Applied RNA Synthesis Workflows with the HyperScribe SP6 Kit

  2026-07-01

  The HyperScribe SP6 High Yield RNA Synthesis Kit empowers advanced RNA biology through high-yield, flexible in vitro transcription. Discover how this SP6 RNA polymerase kit streamlines capped, labeled, and biotinylated RNA synthesis for applications from vaccine research to functional genomics.

• YBX1 and SHANK3 Methylation: Mechanisms in Schizophrenia Pat

  2026-06-30

  This study identifies YBX1-mediated, DNA methylation-dependent regulation of SHANK3 expression in both peripheral blood and developing cortical interneurons of schizophrenia patients. The work establishes promoter hypermethylation of SHANK3 as a potential peripheral biomarker and clarifies the neuron subtype-specific molecular mechanisms underlying disease pathology.

• Ribociclib Succinate: Precision CDK4/6 Inhibition and Progno

  2026-06-30

  Explore the multifaceted role of Ribociclib succinate as a selective CDK inhibitor in advanced cancer research. This article uniquely bridges mechanistic insights, protocol optimization, and the integration of prognostic biomarkers, providing a richer context for translational oncology workflows.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page